| 1. |
Dideban S, Abdollahi A, Meysamie A, et al. Thyroid papillary microcarcinoma:etiology, clinical manifestations, diagnosis, follow-up, histopathology and prognosis. Iran J Pathol, 2016, 11(1):1-19.
|
| 2. |
698 population-based measurement studies with 19·2 million participants. Lancet, 2016, 387(10026):1377-1396.
|
| 3. |
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014:a pooled analysis of.
|
| 4. |
平波. 甲狀腺結節的細胞學檢查. 中國普外基礎與臨床雜志, 2014, 21(9):1070-1075.
|
| 5. |
Huang LY, Lee YL, Chou P, et al. Thyroid fine-needle aspiration biopsy and thyroid cancer diagnosis:a nationwide population-based study. PloS One, 2015, 10(5):e0127354.
|
| 6. |
Moon M, Son E, Kim EK, et al. The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann Surg Oncol, 2012, 19(1):52-59.
|
| 7. |
Zhong LC, Lu F, Ma F, et al. Ultrasound-guided fine-needle aspiration of thyroid nodules:does the size limit its efficiency? Int J Clin Exp Pathol, 2015, 8(3):3155-3159.
|
| 8. |
周樂, 張廣, 張大奇, 等. 超聲引導下甲狀腺結節細針穿刺活檢臨床應用及質量控制研究. 中國實用外科雜志, 2015, 35(6):650-652.
|
| 9. |
周樂, 孫輝. 細針穿刺在甲狀腺微小癌診斷中應用. 中國實用外科雜志, 2016, 36(5):86-88, 90.
|
| 10. |
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology:Thyroid Carcinoma V.1.2016. Available at http://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf[cited Aug 2016].
|
| 11. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with thyroid nodules and differentiated thyroid cancer:The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1):1-133.
|
| 12. |
中國抗癌協會甲狀腺癌專業委員會(CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識(2016版). 2016, 43(10):405-411.
|
| 13. |
Shin JH, Baek JH, Chung J, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules:Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol, 2016, 17(3):370-395.
|
| 14. |
Dralle H, Musholt TJ, Schabram J, et al. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg, 2013, 398(3):347-375.
|
| 15. |
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update:executive summary of recommendations. Endocr Pract, 2016, 22(5):622-639.
|
| 16. |
Park JW, Yoo JS, Yun JK, et al. An online questionnaire survey on preferred timing for the diagnosis and management of thyroid carcinoma in general population in Korea. Ann Surg Treat Res, 2016, 90(6):297-302.
|
| 17. |
Ito Y, Miyauchi A. Nonoperative management of low-risk differentiated thyroid carcinoma. Curr Opin Oncol, 2015, 27(1):15-20.
|
| 18. |
Mehanna H, Al-Maqbili T, Carter B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma:a systematic review and meta-analysis of 21329 person-years of follow-up. J Clin Endocrinol Metab, 2014, 99(8):2834-2843.
|
| 19. |
Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid, 2016, 26(1):144-149.
|
| 20. |
張浩. 甲狀腺微小乳頭狀癌外科治療爭議與共識. 中國實用外科雜志, 2016, 36(5):504-508.
|
| 21. |
Kandil E, Noureldine SI, Tufano RP. Thyroidectomy vs active surveillance for subcentimeter papillary thyroid cancers-the cost conundrum. JAMA Otolaryngol Head Neck Surg, 2016, 142(1):9-10.
|
| 22. |
Breuer C, Tuggle C, Solomon D, et al. Pediatric thyroid disease:when is surgery necessary, and who should be operating on our children? J Clin Res Pediatr Endocrinol, 2013, 5 Suppl 1:79-85.
|
| 23. |
Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer:The American Thyroid Association guidelines task force on pediatric thyroid cancer. Thyroid, 2015, 25(7):716-759.
|
| 24. |
馬潔, 關海霞. 妊娠與甲狀腺癌關聯的研究進展. 中華內分泌代謝雜志, 2014, 30(12):1132-1134.
|
| 25. |
Shindo H, Amino N, Ito Y, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid, 2014, 24(5):840-844.
|
| 26. |
Zhou YQ, Zhou Z, Qian MF, et al. Association of thyroid carcinoma with pregnancy:a meta-analysis. Mol Clin Oncol, 2015, 3(2):341-346.
|
| 27. |
Kuy S, Roman SA, Desai R, et al. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg, 2009, 144(5):399-406.
|
| 28. |
De Groot L,Abalovich M,Alexander EK,et al. Management of thyroid dysfunction during pregnancy and postpartum:an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab,2012,97(8):2543-2565.
|
| 29. |
中華醫學會內分泌學分會,中華醫學會圍產醫學分會. 妊娠和產后甲狀腺疾病診治指南.中華內分泌代謝雜志, 2012,28(5):354-371.
|
| 30. |
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 2014, 24(1):27-34.
|